Metraipolis › archive › dc_1581095ef6e2

Ruxolitinib Penetrates Blood Brain Barrier and Reduces the Cytokine Storm in Patients With Haemophagocytic Lymphohistiocytosis — Europe PMC PMID:42138216

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42138216
DOI
10.1111/jcmm.71173
License (as archived)
solo-consultazione
Archived
2026-11-02T22:08:17.395Z
SHA-256 of the archived text
f3a7ced0f80fb052afeb729b3437b92fa4b0de5bbe07a85e7f12fc2d2349ec55
Stable URL of this page
https://metraipolis.com/documento/dc_1581095ef6e2

How to cite

Ruxolitinib Penetrates Blood Brain Barrier and Reduces the Cytokine Storm in Patients With Haemophagocytic Lymphohistiocytosis — Europe PMC PMID:42138216 — Europe PMC (en), https://europepmc.org/article/MED/42138216 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1581095ef6e2 (Metraipolis archive dc_1581095ef6e2, sha256 f3a7ced0f80fb052afeb729b3437b92fa4b0de5bbe07a85e7f12fc2d2349ec55)
BibTeX
@misc{dc1581095ef6e2,
  title = {Ruxolitinib Penetrates Blood Brain Barrier and Reduces the Cytokine Storm in Patients With Haemophagocytic Lymphohistiocytosis — Europe PMC PMID:42138216},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42138216},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1581095ef6e2; sha256 f3a7ced0f80fb052afeb729b3437b92fa4b0de5bbe07a85e7f12fc2d2349ec55},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42138216. Agents can read the archived copy with the MCP tool read_document.